These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 10027846
1. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. Sprah L, Zivin M, Sket D. J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846 [Abstract] [Full Text] [Related]
2. Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats. Glavan G, Sket D, Zivin M. Mol Pharmacol; 2002 Feb; 61(2):360-8. PubMed ID: 11809861 [Abstract] [Full Text] [Related]
3. The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions. Zivin M, Sprah L, Sket D. Br J Pharmacol; 1996 Nov; 119(6):1187-96. PubMed ID: 8937722 [Abstract] [Full Text] [Related]
4. Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine. Zivin M, Sprah L, Sket D. Eur J Pharmacol; 1998 May 22; 349(2-3):151-7. PubMed ID: 9671092 [Abstract] [Full Text] [Related]
5. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. Krisch I, Bole-Vunduk B, Pepelnak M, Lavric B, Ocvirk A, Budihna MV, Sket D. J Pharmacol Exp Ther; 1994 Oct 22; 271(1):343-52. PubMed ID: 7965734 [Abstract] [Full Text] [Related]
6. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK, Manzino L, Heikkila RE. J Pharmacol Exp Ther; 1988 Oct 22; 247(1):180-5. PubMed ID: 2971797 [Abstract] [Full Text] [Related]
9. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. Wang JQ, McGinty JF. J Pharmacol Exp Ther; 1997 May 22; 281(2):972-82. PubMed ID: 9152408 [Abstract] [Full Text] [Related]
10. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T, Noda T, Satomi M, Ohtaki K, Chiba K, Tasaki Y, Shiono H. Brain Res; 2006 Sep 27; 1112(1):126-33. PubMed ID: 16884702 [Abstract] [Full Text] [Related]
11. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ, Marshall JF. Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899 [Abstract] [Full Text] [Related]
12. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats. Wardas J, Pietraszek M, Ossowska K, Wolfarth S. Pol J Pharmacol; 1995 Jun 01; 47(4):349-53. PubMed ID: 8616516 [Abstract] [Full Text] [Related]
13. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Strömberg I, Kehr J, Andbjer B, Fuxe K. Exp Neurol; 2000 Jul 01; 164(1):154-65. PubMed ID: 10877926 [Abstract] [Full Text] [Related]
17. The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats. Milivojevic N, Krisch I, Sket D, Zivin M. Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun 01; 369(6):576-82. PubMed ID: 15138661 [Abstract] [Full Text] [Related]
20. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. Meller E, Bohmaker K, Goldstein M, Friedhoff AJ. J Pharmacol Exp Ther; 1985 Jun 01; 233(3):656-62. PubMed ID: 2861276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]